151 related articles for article (PubMed ID: 23441711)
1. Bariatric surgery and diabetes: access denied.
Chapman WH; Cunningham E; Pories WJ
Diabetes Technol Ther; 2013 Feb; 15 Suppl 1(Suppl 1):S83-7. PubMed ID: 23441711
[No Abstract] [Full Text] [Related]
2. Bariatric surgery in patients with morbid obesity and type 2 diabetes.
Schernthaner G; Morton JM
Diabetes Care; 2008 Feb; 31 Suppl 2():S297-302. PubMed ID: 18227500
[No Abstract] [Full Text] [Related]
3. Bariatric surgery: an attractive therapeutic modality for type 2 diabetes mellitus.
Dugum M; El-Hayek K; Garg S
Diabetes Technol Ther; 2014 Sep; 16(9):547-9. PubMed ID: 25068437
[No Abstract] [Full Text] [Related]
4. Editors' comment: bariatrics and diabetes meta-analysis.
Buchwald H; Scopinaro N
Obes Surg; 2009 May; 19(5):543. PubMed ID: 19367437
[No Abstract] [Full Text] [Related]
5. Advances in bariatric and metabolic surgery.
Pasupathy S
Ann Acad Med Singap; 2014 Apr; 43(4):232-4. PubMed ID: 24833076
[No Abstract] [Full Text] [Related]
6. Clinical considerations for the management of residual diabetes following bariatric surgery.
Kashyap SR; Schauer P
Diabetes Obes Metab; 2012 Sep; 14(9):773-79. PubMed ID: 22288474
[TBL] [Abstract][Full Text] [Related]
7. Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom.
Yska JP; van Roon EN; de Boer A; Leufkens HG; Wilffert B; de Heide LJ; de Vries F; Lalmohamed A
JAMA Surg; 2015 Dec; 150(12):1126-33. PubMed ID: 26422580
[TBL] [Abstract][Full Text] [Related]
8. Associations between Lifetime Adversity and Obesity Treatment in Patients with Morbid Obesity.
Rønningen R; Wammer ACP; Grabner NH; Valderhaug TG
Obes Facts; 2019; 12(1):1-13. PubMed ID: 30654360
[TBL] [Abstract][Full Text] [Related]
9. Bariatric surgery for type 2 diabetes: to whom and when?
Samaras K
Minerva Endocrinol; 2013 Mar; 38(1):47-58. PubMed ID: 23435442
[TBL] [Abstract][Full Text] [Related]
10. Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2.
Cummings DE; Cohen RV
Diabetes Care; 2016 Jun; 39(6):924-33. PubMed ID: 27222550
[TBL] [Abstract][Full Text] [Related]
11. Bariatric surgery for obese adolescents to prevent type 2 diabetes.
Beamish AJ
BMJ; 2016 Jun; 353():i2977. PubMed ID: 27250637
[No Abstract] [Full Text] [Related]
12. Morbid obesity and type 2 diabetes alter intestinal fatty acid uptake and blood flow.
Koffert J; Ståhle M; Karlsson H; Iozzo P; Salminen P; Roivainen A; Nuutila P
Diabetes Obes Metab; 2018 Jun; 20(6):1384-1390. PubMed ID: 29352513
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.
Adams TD; Arterburn DE; Nathan DM; Eckel RH
Diabetes Care; 2016 Jun; 39(6):912-23. PubMed ID: 27222549
[TBL] [Abstract][Full Text] [Related]
14. Intestinal gluconeogenesis: another weight loss-independent antidiabetic effect of metabolic surgery.
Cohen RV
Surg Obes Relat Dis; 2017 Apr; 13(4):630-631. PubMed ID: 28237560
[No Abstract] [Full Text] [Related]
15. [Metabolic surgery--a new approach to the management of selected diseases].
Fried M; Dolezalová K
Vnitr Lek; 2011 Apr; 57(4):402-4. PubMed ID: 21612068
[TBL] [Abstract][Full Text] [Related]
16. Efficacy in type 2 diabetes mellitus remission in patients undergoing bariatric surgery.
Pereyra-García Castro FM; Oliva García JG; García Nuñez MA; García Bray BF; Suarez Llanos JP; Moneva Arce ME; Palacio Abizanda JE
Endocrinol Diabetes Nutr (Engl Ed); 2019 Jan; 66(1):56-61. PubMed ID: 30392998
[TBL] [Abstract][Full Text] [Related]
17. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates.
Gersin KS; Rothstein RI; Rosenthal RJ; Stefanidis D; Deal SE; Kuwada TS; Laycock W; Adrales G; Vassiliou M; Szomstein S; Heller S; Joyce AM; Heiss F; Nepomnayshy D
Gastrointest Endosc; 2010 May; 71(6):976-82. PubMed ID: 20304396
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
[TBL] [Abstract][Full Text] [Related]
19. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
Mingrone G
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Weight Loss and Metabolic Syndrome Remission after Bariatric Surgery: The Effect of Sex, Age, Metabolic Parameters and Surgical Technique - A 4-Year Follow-Up Study.
Guerreiro V; Neves JS; Salazar D; Ferreira MJ; Oliveira SC; Souteiro P; Pedro J; Magalhães D; Varela A; Belo S; Freitas P; Carvalho D;
Obes Facts; 2019; 12(6):639-652. PubMed ID: 31747662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
